Visby's multi-viral Medical Flu and Covid-19 test yields results in 30 minutes.

Automated quality control using rapid PCR assays is replacing 28-day culture tests, cutting biopharmaceutical lot release ...

Co-Diagnostics Inc. (NASDAQ:CODX) on Wednesday said it completed clinical and analytical performance studies for the Co-Dx ...

Bobbie, the mission-driven infant formula manufacturer, announced a significant evolution of its testing and quality ...

It’s a bit like giving the soil a DNA test.” A new droplet digital PCR (ddPCR) method quantifies root DNA directly from soil ...

Visby Medical, the at-home diagnostics company, today announced U.S. Food and Drug Administration (FDA) clearance for the Visby Medical Flu and COVID-19 Test, the first multi-viral at-home PCR test.

CDT. Biocartis and Discovery Life Sciences Announce Strategic Collaboration to Advance Precision Oncology Diagnostics. ITASCA ...

Cepheid, a Danaher company and a leader in molecular diagnostics, today announced the publication of a study demonstrating the real-world impact of the Xpert Xpress MVP (multiplex vaginal panel) test ...

Alzheimer’s blood test breakthrough: 34 circular RNA biomarkers validated in nearly 2,400 patients outperform the pTau217 ...

A new study will look at rapid COVID-19 tests at Toronto's Pearson airport. The Greater Toronto Airports Authority says the research will allow for widescale workplace testing. The tests should be ...

The ultra-sensitive test can find hidden signs of pancreatic cancer by looking for a key KRAS genetic mutation missed by ...

Scientists say it has the potential to extend lives by helping doctors identify patients whose disease is more likely to ...